CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam

Tropical Medicine and International Health

Volumn 9, Issue 2, 2004, Pages 209-216

  Giao, Phan T ^a,b   De Vries, Peter J ^a   Hung, Le Q ^a,b   Binh, Tran Q ^b   Nam, Nguyen V ^c   Kager, Piet A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CHO RAY HOSPITAL   (Viet Nam)

^c Binh Thuan Prov Malaria Station   (Viet Nam)

Author keywords

Atovaquone; Combination therapy; Dihydroartemisinin; Piperaquine; Plasmodium falciparum; Primaquine; Proguanil; Trimethoprim; Vietnam

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; CV 8; DIHYDROARTEMISININ; PIPERAQUINE; PRIMAQUINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

DISEASE TREATMENT; DRUG PRESCRIBING; DRUG RESISTANCE; MALARIA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; FEMALE; FOLLOW UP; HALF LIFE TIME; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PRURITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TABLET FORMULATION; TREATMENT OUTCOME; VIET NAM; VOMITING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHLOROGUANIDE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; NAPHTHOQUINONES; PARASITEMIA; PLASMODIUM FALCIPARUM; PRIMAQUINE; QUINOLINES; SESQUITERPENES; TREATMENT OUTCOME; TRIMETHOPRIM; VIETNAM;

ASIA; EURASIA; SOUTHEAST ASIA; VIET NAM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 1342322720     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01180.x     Document Type: Article

References (40)

1. Arnold J, Alving AS, Hockwald RS et al. (1955) The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama,P.F-6 strain). Journal of Laboratory and Clinical Medicine 46, 391-396.
2. Basco LK & Ringwald P (2000) Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. American Journal of Tropical Medicine & Hygiene 63, 215-221.
3. Binh TQ, Ilett KF, Batty KT et al. (2001) Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria. British Journal of Clinical Pharmacology 51, 541-546.
4. Bustos DG, Canfield CJ, Editha CM & Hutchinson DB (1999) Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine- pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippine. Journal of Infectious Diseases 179, 1587-1590.
5. Chen L (1991) Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine. Chinese Medical Journal 104, 161-163.
6. Chen L, Qu FY & Zhou YC (1982) Field observations on the antimalarial piperaquine. Chinese Medical Journal 95, 281-286.
7. Chen L, Qian Y & Li Z (1986) Effects of piperaquine on fine structure of erythrocytic stages of Plasmodium berghei ANKA strain. Acta Pharmacologica Sinica 7, 351-353.
8. Deloron P, Le Bras J, Ramanamirija JA & Coulanges P (1985) Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Annals of Tropical Medicine & Parasitology 79, 357-365.
9. Denis MB, Davis TM, Hewitt S et al. (2002) Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Diseases 35, 1469-1476.
10. Ding G-S (1988) Recent studies on antimalarials in China: a review of literature since 1980. International Journal of Experimental and Clinical Chemotherapy 1, 9-22.
11. Giao PT & de Vries PJ (2001b) Pharmacokinetic interactions of antimalarial agents. Clinical Pharmacokinetics 40, 343-373.
12. Giao PT, Binh TQ, Kager PA et al. (2001a) Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? American Journal of Tropical Medicine and Hygiene 65, 690-695.
13. Hudson AT, Dickins M, Ginger CD et al. (1991) 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs under Experimental and Clinical Research 17, 427-435.
14. Hung TY, Davis TME & Ilett KF (2003) Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection. Journal of Chromatography B 791, 93-101.
15. Iyer JK, Milhous WK, Cortese JF, Kublin JG & Plowe CV (2001) Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358, 1066-1067.
16. Lafaix C, Ray M, Mar ID & Nouhouayi A (1967) Essai de traitement curatif du paludisme pour un nouvel antipaludique de synthese, le 16-126 RP. Bulletin de Societe Medicine d'Afrique Noire, Langue Francais 12, 546-551.
17. Le NH, de Vries PJ, Le TD et al. (1997) Single dose artemisinin- mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 191-194.
18. Le NH, Na-Bangchang K, Le TD, Thrinh KA & Karbwang J (1999) Phamacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunteers. Southeast Asian Journal of Tropical Medicine and Public Health 30, 11-16.
19. Li GQ, Wang XH, Guo XB et al. (1999) Dose findings of dihydroartemisinin in treatment of falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 30, 17-19.
20. Looareesuwan S, Chulay JD, Canfield CJ & Hutchinson DB (1999a) Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. American Journal of Tropical Medicine and Hygiene 60, 533-541.
21. Looareesuwan S, Wilairatana P, Chalermarut K et al. (1999b) Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene 60, 526-532.
22. McIntosh HM & Olliaro P (2000) Artemisinin derivatives for treating uncomplicated malaria (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Update Software, Oxford.
23. Na-Bangchang K, Tippanangkosol P, Ubalee R et al. (1999) Comparative clinical trial of four regimens of dihydroartemisinin-mefloquine in multidrug-resistant falciparum malaria. Tropical Medicine and International Health 4, 602-610.
24. Newton PN, van Vugt M, Teja-Isavadharm P et al. (2002) Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria. Antimicrobial Agents and Chemotherapy 46, 1125-1127.
25. Nontprasert A, Pukrittayakamee S, Prakongpan S et al. (2002) Assessment of the neurotoxicity of oral dihydroartemisinin in mice. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 99-101.
26. Slater AF (1993) Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacology and Therapeutics 57, 203-235.
27. Srivastava IK & Vaidya AB (1999) A mechanism for the synergistic antimalaria action of atovaquone and Proguanil. Antimicrobial Agents and Chemotherapy 43, 1334-1339.
28. Thompson PE & Werbel LM (1972) Pyrimidines: Pyrimethamine Type: In Antimalarial Agents. Academic Press, New York and London, pp. 227-229.
29. Tien NT, Uyen TT, Huong DX & Nhan DH (2002) Efficacy of CV8 for treatment of drug-resistant falciparum malaria. Journal of Malaria and Parasite Diseases Control, 37-40.
30. Tip NQ, Trung TN, Tan TV & Phuc NT (2001) A field trial for efficacy of CV8 in treatment of uncomplicated falciparum malaria. Journal of Malaria and Parasite Diseases Control, 45-51.
31. Vennerstrom JL, Ellis WY, Ager AL, Jr et al. (1992) Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. Journal of Medicinal Chemistry 35, 2129-2134.
32. de Vries PJ & Dien TK (1996) Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52, 818-836.
33. de Vries PJ, Bich NN, Van Thien H et al. (2000) Combinations of artemisinin and quinine for uncomplicated falciparum malaria: efficacy and pharmacodynamics. Antimicrobial Agents and Chemotherapy 44, 1302-1308.
34. van Vugt M, Leonardi E, Phaipun L et al. (2002) Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone- proguanil. Clinical Infectious Diseases 35, 1498-1504.
35. Wang W, Yang W & Micha ST (2001) Efficacy of dihydroartemisinin- mefloquine on acute uncomplicated falciparum malaria. Chinese Medical Journal 114, 612-613.
36. White NJ (1999) Antimalarial drug resistance and combination chemotherapy. Philophical Transactions of the Royal Society of London B 354, 739-749.
37. Wilairatna P, Krudsood S, Silachamroon U et al. (2000) Clinical trial of sequential treatments of moderately severe and severe malaria with dihydroartemisinin suppository followed by mefloquine in Thailand. American Journal of Tropical Medicine and Hygiene 63, 290-294.
38. World Health Organization (2002) Report Meeting on Antimalarial Drug Development, Shanghai, China, 16-17 November 2001. RS/2001/GE/33(CHN). World Health Organization, Regional Office for the Western Pacific, Manila, Philippines.
39. Youel DB, Strickland GT, Binh BA, Clarkson R & Blackwell RQ (1971) Low incidence of erythrocyte G-6-P D deficiency in Vietnamese and Montagnards of South Vietnam. Vox Sanguinis 20, 555-558.
40. Zhu DQ, Dai ZR, Li JC & Jiang ZK (1982) Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice. Yao Hsueh Hsueh Pao - Acta Pharmaceutica Sinica 17, 894-898.